Women's Perceptions of Polycystic Ovary Syndrome Following Participation in a Clinical Research Study: Implications for Knowledge, Feelings, and Daily Health Practices

Journal of Obstetrics and Gynaecology Canada

Volumn 32, Issue 5, 2010, Pages 453-459

  Colwell, Katie ^a   Lujan, Marla E ^a   Lawson, Karen L ^b   Pierson, Roger A ^a   Chizen, Donna R ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Insulin resistance; Lifestyle modification; Metabolic syndrome; Polycystic ovary syndrome; Quality of life

Indexed keywords

ADULT; ARTICLE; ATTITUDE TO HEALTH; DIET; FEMALE; HEALTH BEHAVIOR; HEALTH CARE; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVARY POLYCYSTIC DISEASE; PATIENT COUNSELING; PATIENT EDUCATION; PHYSICAL ACTIVITY; SATISFACTION; SYMPTOM; ADOLESCENT; LIFESTYLE; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RESEARCH SUBJECT;

ADOLESCENT; ADULT; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; LIFE STYLE; POLYCYSTIC OVARY SYNDROME; QUESTIONNAIRES; RESEARCH SUBJECTS;

EID: 77954895235     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)34499-1     Document Type: Article

References (23)

1. Knochenhauer E.S., Key T.J., Kahsar-Miller M., Waggoner W., Boots L.R., Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998, 83:3078-3082.
2. Azziz R. The Rotterdam 2003 Criteria for Defining PCOS: con (or how to define a syndrome). J Clin Endocrinol Metab 2006, Jan 17. DOI:10.1210/jc.2005-2153. Available at: Accessed March 10, 2010. http://jcem.endojournals.org/cgi/content/abstract/jc.2005-2153v1.
3. Azziz R. PCOS: a diagnostic challenge. Reprod Biomed Online 2004, 8:644-648.
4. Rotterdam EA-SPCWG Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004, 81:19-25.
5. Humphreys L., Costarelli V. Implementation of dietary and general lifestyle advice among women with polycystic ovarian syndrome. J R Soc Health 2008, 128:190-196.
6. Barnard L., Ferriday D., Guenther N., Strauss B., Balen A.H., Dye L. Quality of life and psychological well being in polycystic ovary syndrome. Hum Reprod 2007, 22:2279-2286.
7. Ching H.L., Burke V., Stuckey B.G.A. Quality of life and psychological morbidity in women with polycystic ovary syndrome: body mass index, age and the provision of patient information are significant modifiers. Clin Endocrinol 2007, 66:373-379.
8. Himelein M.J., Thatcher S.S. Polycystic ovary syndrome and mental health: a review. Obstet Gynecol Surv 2006, 61:723-732.
9. Avery J.C., Braunack-Mayer A.J. The information needs of women diagnosed with polycystic ovarian syndrome-implications for treatment and health outcomes. BMC Womens Health 2007, 7:9.
10. Lujan M.E., Chizen D.R., Peppin A.K., Kriegler S., Leswick D.A., Bloski T.G., et al. Improving inter-observer variability in the evaluation of ultrasonographic features of polycystic ovaries. Reprod Biol Endocrinol 2008, 6:30.
11. Lujan M.E., Chizen D.R., Peppin A.K., Dhir A., Pierson R.A. Assessment of ultrasonographic features of polycystic ovaries is associated with modest levels of inter-observer agreement. J Ovarian Res 2009, 2:6. Accessed March 10, 2010. http://www.ovarianresearch.com/content/2/1/6.
12. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004, 19:41-47.
13. Kolodziejczyk B., Duleba A.J., Spaczynski R.Z., Pawelczyk L. Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome. Fertil Steril 2000, 73:1149-1154.
14. Hoeger K.M. Role of lifestyle modification in the management of polycystic ovary syndrome. Best Pract Res Clin Endocrinol Metab 2006, 20:293-310.
15. Moran L.J., Pasquali R., Teede H.J., Hoeger K.M., Norman R.J. Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society. Fertil Steril 2009, 92:1966-1982.
16. Huber-Buchholz M.M., Carey D.G., Norman R.J. Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone. J Clin Endocrinol Metab 1999, 84:1470-1474.
17. Moghetti P., Castello R., Negri C., Tosi F., Perrone F., Caputo M., et al. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab 2000, 85:139-146.
18. Aruna J., Mittal S., Kumar S., Misra R., Dadhwal V., Vimala N. Metformin therapy in women with polycystic ovary syndrome. Int J Gynaecol Obstet 2004, 87:237-241.
19. Yilmaz M., Biri A., Karakoç A., Törüner F., Bingöl B., Cakir N., et al. The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome. J Endocrinol Invest 2005, 28:1003-1008.
20. Yilmaz M., Karakoç A., Toruner F.B., Cakir N., Tiras B., Ayvaz G., et al. The effects of rosiglitazone and metformin on menstrual cyclicity and hirsutism in polycystic ovary syndrome. Gynecol Endocrinol 2005, 21:154-160.
21. Alm-Roijer C., Fridlund B., Stagmo M., Erhardt L. Knowing your risk factors for coronary heart disease improves adherence to advice on lifestyle changes and medication. J Cardiovasc Nurs 2006, 21:E24-F31.
22. Saito Y.A., Prather C.M., Van Dyke C.T., Fett S., Zinsmeister A.R., Locke G.R. Effects of multidisciplinary education on outcomes in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2004, 2:576-584.
23. Tuomilehto J., Lindstrom J., Eriksson J.G., Valle T.T., Hämäläinen H., Ilanne-Parikka P. Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001, 344:1343-1350.